Research progress on ferroptosis in Myelodysplastic syndromes
Myelodysplastic syndromes (MDS) are a group of malignancies characterized by clonal proliferation of hematopoietic stem cells, ineffective hematopoiesis, peripheral cytopenias, and a high risk of transformation to acute myeloid leukemia. Current therapeutic strategies for MDS have limited efficacy....
Saved in:
| Main Authors: | Yifan Yang, Jiongping Han, Yuxin Wei, Jiacheng Jin, Weiyin Feng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1561072/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Asiaticoside alleviates ferroptosis in myelodysplastic syndrome by activating SMAD7
by: WANG Liye, et al.
Published: (2025-06-01) -
A correlation of ineffective erythropoiesis and dysregulated signaling pathways in myelodysplastic syndromes/neoplasms
by: Junying Wu, et al.
Published: (2025-05-01) -
FAR1 as a ferroptosis-related biomarker and potential therapeutic target in acute kidney injury: integrated bioinformatics and experimental validation
by: Hao Duan, et al.
Published: (2025-12-01) -
Identification of new hub- ferroptosis-related genes in Lupus Nephritis
by: Xiao-Jie Zheng, et al.
Published: (2024-12-01) -
Pomolic acid induces ferroptosis-mediated cell death in non-small cell lung cancer
by: Wenbin Ji, et al.
Published: (2025-06-01)